The analysts said GLP-1 sales could reach $102 billion by 2030, of which obesity is projected to contribute $41 billion. Two leaders in this field are expected to take roughly 44% and 52% share, respectively, of the global GLP-1 market in 2030. With high financial gain predicted, supply issues have been raised concerning how companies will meet the growing demand
He emphasized that Wegovy is not intended for people who just want to drop a few pounds
The incidence and outcome of perioperative pulmonary aspiration in a university hospital: a 4-year retrospective analysis
Operating on a body that is still changing can compromise your results
A nutrition tracker helps you log and understand your own patterns, but it is not a substitute for personalised dietary or medical advice
For many, stress increases cravings, especially for high-calorie comfort foods